(S, R, S)-AHPC-C2-NH2 dihydrochloride - CAS# 2341796-73-2 Catalog No.:M11543-2 other myeloid malignancies and solid

other myeloid malignancies and solid tumors

The furanodiene-induced decrease of p-Akt and Akt expressions is enhanced by the Akt inhibitor VIII pretreatment

Thalidomide-OH has weak anti-angiogenic activity (14% mean inhibition of blood vessel density at 100 mg)

3-b']difuran-6-acetic acid

SB-3CT inhibits MMP-9 with an inhibition constant Ki of 400±15 nM

(S, R, S)-AHPC-C2-NH2 dihydrochloride - CAS# 2341796-73-2 Catalog No.:M11543-2 other myeloid malignancies and solid(S, R, S) AHPC C2 NH2 dihydrochloride incorporates a VHL ligand for the E3 ubiquitin ligase, and a PROTAC linker. (S, R, S) AHPC OH can be used in the synthesis of a series of PROTACs. Product information CAS Number: 2341796 73 2 Molecular Weight: 574. 56 Formula: C25H37Cl2N5O4S Chemical Name: (2S, 4R) 1 [(2S) 2 (3 aminopropanamido) 3, 3 dimethylbutanoyl] 4 hydroxy N {[4 (4 methyl 1, 3 thiazol 5 yl)phenyl]methyl}pyrrolidine 2 carboxamide